RARE - Ultragenyx Pharmaceutical Inc.


21.8
-0.270   -1.239%

Share volume: 2,251,986
Last Updated: 03-04-2026
Pharmaceutical Products/Pharmaceutical Preparations: 3.72%

PREVIOUS CLOSE
CHG
CHG%

$22.07
-0.27
-0.01%
5D - 1M - 3M - 1Y - 3Y - 5Y - 10Y - 15Y
Income statement Balance sheet Cash flow To see more then 2 years history Buy Premium
View ratios

Fiscal Date 03-31-2024 06-30-2024 09-30-2024 12-31-2024 03-31-2025 06-30-2025 09-30-2025 12-31-2025
Fiscal Quarter Q1 2024 Q2 2024 Q3 2024 Q4 2024 Q1 2025 Q2 2025 Q3 2025 Q4 2025
Report Date 05-03-2024 08-02-2024 11-05-2024 02-19-2025 05-06-2025 08-05-2025 11-04-2025 02-18-2026
Cash flow financing -58.000 K 384.939 M 11.174 M 3.186 M 157.000 K 83.649 M 2.000 K 394.192 M
Other financing cash flows 0.000 0.000 0.000 0.000 0.000 0.000 0.000 0.000
Cash flow -190.727 M -76.963 M -331.323 M 26.418 M -46.428 M 46.551 M 25.761 M 222.116 M
Net income -170.684 M -131.598 M -133.516 M -133.385 M -151.080 M -114.951 M -180.413 M -128.556 M
Depreciation 8.845 M 8.862 M 8.757 M 9.079 M 8.990 M 8.619 M 8.606 M 8.785 M
Changes in inventories 35.907 M 40.137 M 0.000 0.000 763.000 K 0.000 0.000 0.000
Changes in receivables 100.253 M 105.982 M 0.000 0.000 0.000 0.000 0.000 0.000
Investing Cashflow 94.435 M 60.564 M -275.502 M 102.735 M 119.890 M 71.175 M 117.182 M -72.247 M
Net Borrowings -459.807 M -818.521 M 0.000 0.000 0.000 0.000 0.000 0.000
Investing Activity Other 0.000 0.000 -203.000 K -127.000 K -780.000 K -308.000 K -185.000 K 273.000 K
Dividends Paid 0.000 0.000 0.000 0.000 0.000 0.000 0.000 0.000
Exchange Rate Effect 0.000 0.000 0.000 0.000 0.000 0.000 0.000 0.000
Capital Expenditures -13.211 M -4.509 M 1.617 M 654.000 K 1.324 M 2.460 M 1.278 M 938.000 K
Cash Change 412.080 M 763.821 M -330.048 M 23.945 M -44.980 M 49.465 M 26.055 M 221.460 M